Indices
Nifty 50
ADANIENT2,470.60−3.11% ADANIPORTS1,695.00−3.14% APOLLOHOSP7,584.50−0.26% ASIANPAINT2,266.00−0.82% AXISBANK1,204.90−0.59% BAJAJ-AUTO10,052.00−1.01% BAJAJFINSV1,643.20−2.07% BAJFINANCE919.95−2.35% BEL356.50−2.19% BHARTIARTL1,864.00−1.64% BSE3,208.50−1.73% CIPLA1,319.30−0.87% COALINDIA392.05−2.61% DRREDDY1,226.70−0.99% EICHERMOT6,967.00−1.66% ETERNAL312.10+2.51% GRASIM2,874.90−0.67% HCLTECH1,424.70+0.21% HDFCBANK694.00−0.01% HDFCLIFE517.25−2.10% HINDALCO862.50−2.61% HINDUNILVR1,784.70−2.38% ICICIBANK1,389.00−0.68% INDIGO4,506.00−2.04% INFY1,158.20+0.42% ITC256.85−0.79% JIOFIN203.65−3.39% JSWSTEEL1,194.70−2.07% KOTAKBANK430.85−1.41% LT3,604.80−0.92% M&M2,816.50−1.66% MARUTI11,061.00−0.98% MAXHEALTH816.10−0.11% NESTLEIND1,160.80−2.45% NTPC293.15−3.12% ONGC225.000.00% POWERGRID242.70−2.29% RELIANCE1,172.50−1.01% SBILIFE1,621.60−1.30% SBIN952.40−1.81% SHRIRAMFIN871.35−3.28% SUNPHARMA1,740.40−1.00% TATACONSUM950.20−1.00% TATASTEEL164.05−4.80% TCS2,540.80+1.35% TECHM1,791.90−2.03% TITAN4,219.10−3.01% TMPV260.80−3.41% TRENT2,691.60−3.03% ULTRACEMCO10,861.00−0.89%

Emcure Pharmaceuticals share price

Emcure Pharmaceuticals Ltd. · NSE: EMCURE · Healthcare

₹1,750.10 −32.50 −1.82%
Live · 23 Oct 2026, 12:39 IST

Price, one year

1 year agoLow 1,318.90 · High 2,009.60Latest close
1W−4.48%
1M−11.28%
3M−5.64%
6M+11.92%
1Y+30.06%

Price range

Open
₹1,776.00
High
₹1,799.00
Low
₹1,724.80
Previous close
₹1,782.60
Volume
1.1 L
Market cap
₹33,201 Cr
Day range
52-week range

Key statistics

Results to 30 Jun 2026 · Consolidated
P/E (TTM)
33.4
Price to book
6.8
Return on equity
20.4%
EPS (TTM)
₹53.35
Book value / share
₹260.93
Debt to equity
0.24
Revenue (TTM)
₹9,683 Cr
Net profit (TTM)
₹1,011 Cr
Sales growth, YoY
+22.9%
Profit growth, YoY
+42.0%
Operating margin
20.4%
Net margin
10.4%
Sales CAGR, 3 years
—
Profit CAGR, 3 years
—
Promoter holding
77.82%
Promoter shares pledged
0.04%
From the company's results filed with NSE; TTM is the last four quarters. Ratios use the latest price.

Shareholding pattern

% of shares
HolderSep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters77.8877.8777.8777.8377.82
Foreign institutions3.293.593.354.884.94
Domestic institutions4.376.106.108.468.49
Mutual funds3.584.834.946.877.05
Retail and others6.236.456.466.456.34
Promoter pledge0.040.040.040.040.04

Results and announcements

Latest results (quarter to 30 Jun 2026) filed 6 Aug 2026. results: 3 Nov 2026.

Exchange filings as published on NSE; routine filings are left out.

Peers in Healthcare

All Healthcare stocks
CompanyPriceChangeMarket capP/E
Sun Pharmaceutical IndustriesSUNPHARMA ₹1,740.40 −1.00% ₹4,17,580 Cr 34.9
Divi's LaboratoriesDIVISLAB ₹8,881.00 −3.07% ₹2,35,763 Cr 83.1
Torrent PharmaceuticalsTORNTPHARM ₹4,487.80 −2.76% ₹1,70,701 Cr 73.7
Zydus LifesciencesZYDUSLIFE ₹1,124.80 −0.90% ₹1,12,199 Cr 25.3
Apollo Hospitals EnterpriseAPOLLOHOSP ₹7,584.50 −0.26% ₹1,09,053 Cr 52.3
CiplaCIPLA ₹1,319.30 −0.87% ₹1,06,582 Cr 31.9
Laurus LabsLAURUSLABS ₹1,943.10 −2.97% ₹1,04,988 Cr 98.8
Dr. Reddy's LaboratoriesDRREDDY ₹1,226.70 −0.99% ₹1,02,390 Cr 32.0
Mankind PharmaMANKIND ₹2,228.10 −2.09% ₹92,031 Cr 46.0
Aurobindo PharmaAUROPHARMA ₹1,557.50 −3.31% ₹89,615 Cr 25.2

Frequently asked questions

What is the share price of Emcure Pharmaceuticals today?

Emcure Pharmaceuticals (NSE: EMCURE) was at ₹1,750.10 on 23 Oct 2026, a change of −1.82% from the previous close.

What are the 52-week high and low of Emcure Pharmaceuticals?

Over the last 52 weeks Emcure Pharmaceuticals traded between ₹1,306.50 and ₹2,100.70 (daily highs and lows on NSE on 23 Oct 2026).

What is the market capitalisation of Emcure Pharmaceuticals?

About ₹33,201 Cr at the latest price, with a P/E of 33.4, a price-to-book of 6.8, a return on equity of 20.4%. Ratios use the company's latest reported results.

Who owns Emcure Pharmaceuticals shares?

According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 77.82%, foreign institutions 4.94%, domestic institutions 8.49%.

Which sector and indices does Emcure Pharmaceuticals belong to?

NSE classifies Emcure Pharmaceuticals under Healthcare; it is a member of Nifty 500.

Follow Emcure Pharmaceuticals with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.

Get started free